These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 10676908)

  • 21. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
    Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
    Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor.
    Kasahara S; Hara T; Itoh H; Ando K; Tsurumi H; Sawada M; Yamada T; Ohnishi H; Moriwaki H
    Br J Haematol; 2002 Jul; 118(1):181-8. PubMed ID: 12100146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The current perspective of low-grade myelodysplastic syndrome in children.
    Hasegawa D
    Int J Hematol; 2016 Apr; 103(4):360-4. PubMed ID: 26939774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
    Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
    Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and treatment of aplastic anemia and lower-risk myelodysplastic neoplasms].
    Suzuki T
    Rinsho Ketsueki; 2024; 65(9):884-891. PubMed ID: 39358287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010.
    Malcovati L; de Latour RP; Risitano A
    Leuk Res; 2011 Mar; 35(3):291-4. PubMed ID: 21036397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes.
    Giudice V; Wu Z; Kajigaya S; Fernandez Ibanez MDP; Rios O; Cheung F; Ito S; Young NS
    Cytokine; 2019 Jan; 113():462-465. PubMed ID: 29958797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF
    Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
    Cha CH; Park CJ; Chi HS; Seo EJ; Jang S; Cho YU; Lee KH; Lee JH; Lee JH; Im HJ; Seo JJ
    Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014.
    Visconte V; Lindsley RC; Berlyne D
    Leuk Res; 2015 Jan; 39(1):110-3. PubMed ID: 25435026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
    Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A
    Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Border between aplastic anemia and myelodysplastic syndrome.
    Yamazaki H; Nakao S
    Int J Hematol; 2013 May; 97(5):558-63. PubMed ID: 23613266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myelodysplastic syndrome with der (1;7) transformed from aplastic anemia 42 years after onset].
    Kanemura N; Tsurumi H; Hara T; Yamada T; Moriwaki H
    Rinsho Ketsueki; 2005 May; 46(5):372-4. PubMed ID: 16444972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.
    Orazi A; Albitar M; Heerema NA; Haskins S; Neiman RS
    Am J Clin Pathol; 1997 Mar; 107(3):268-74. PubMed ID: 9052376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired aplastic anemia.
    Keohane EM
    Clin Lab Sci; 2004; 17(3):165-71. PubMed ID: 15314891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Detection of Myelodysplastic Syndrome/Leukemia-associated Mutations Using NGS Is Critical in Treating Aplastic Anemia.
    Li X; Wu YH; Cai SS; Li WM; You Y; Zhang M
    Curr Med Sci; 2019 Apr; 39(2):217-221. PubMed ID: 31016513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes].
    Tamai Y; Takami H; Nakahata R; Nakui Y; Suzuki Y; Akagi T; Kariya K; Tsushima K; Munakata A; Kawamura S
    Rinsho Ketsueki; 1997 Dec; 38(12):1243-8. PubMed ID: 9455142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of aplastic anemia and myelodysplastic syndrome.
    Paquette RL
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):153-61. PubMed ID: 12380966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ferrokinetics and bone marrow scanning in patients with myelodysplastic syndrome, hypoplastic myelodysplastic syndrome and aplastic anemia].
    Ohno Y; Takahashi Y; Yoshida Y
    Rinsho Ketsueki; 1993 Mar; 34(3):260-4. PubMed ID: 8479076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.